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Abstract 
Objective: To systematically review clinical prediction rules (CPRs) that have undergone validation testing for predicting response 
to physiotherapy-related interventions for musculoskeletal conditions. 
Study design and setting: PubMed, EMBASE, CINAHL and Cochrane Library were systematically searched to September 2020. 
Search terms included musculoskeletal (MSK) conditions, physiotherapy interventions and clinical prediction rules. Controlled studies 
that validated a prescriptive CPR for physiotherapy treatment response in musculoskeletal conditions were included. Two independent 
reviewers assessed eligibility. Original derivation studies of each CPR were identified. Risk of bias was assessed with the PROBAST 
tool (derivation studies) and the Cochrane Effective Practice and Organisation of Care group criteria (validation studies). 
Results: Nine studies aimed to validate seven prescriptive CPRs for treatment response for MSK conditions including back pain, 
neck pain, shoulder pain and carpal tunnel syndrome. Treatments included manipulation, traction and exercise. Seven studies failed 
to demonstrate an association between CPR prediction and outcome. Methodological quality of derivation studies was poor and for 
validation studies was good overall. 
Conclusion: Results do not support the use of any CPRs identified to aid physiotherapy treatment selection 
for common musculoskeletal conditions, due to methodological shortcomings in the derivation studies and lack of 
association between CPR and outcome in validation studies. © 2021 The Authors. Published by Elsevier Inc. 
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 




















Clinical prediction rules (CPRs) can support evidence-
based decision-making at the point of patient care [1] .
CPRs quantify the contribution of multiple predictors from
a patient’s history, examination or diagnostic tests and
stratify patients according to the probability of having spe-
cific diagnostic, prognostic or therapeutic outcomes [2] .
Before widespread implementation, CPRs should undergo
three development stages: (i) Derivation: predictors are
identified and combined; (ii) Validation: the CPR is tested∗ Corresponding author: 
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( http://creativecommons.org/licenses/by/4.0/ ) for discrimination and calibration and (iii) Impact analysis:
the CPR is tested in terms of patient outcomes, clinician
behaviour and/or costs [2] . 
Most CPRs provide diagnostic or prognostic probabil-
ities for individual patient outcomes and methodological
guidance has been published to support their development
[3-5] . In physiotherapy practice, CPRs are most commonly
used in musculoskeletal physiotherapy, where many CPRs
are “prescriptive” and used to decide which patients will
benefit most from treatment [6-10] . Prescriptive CPRs are
more complex than diagnostic or prognostic rules as they
predict differences in outcomes under different conditions,
and their development requires experimental studies to ex-
amine effectiveness [8 , 11 , 12] . The 2013 PROGnosis RE-ess article under the CC BY license 
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Key findings 
• Nine studies aimed to validate 7 CPRs for physio- 
therapy response in MSK conditions. 
What this adds. 
• Seven studies failed to demonstrate association be- 
tween CPR prediction and outcome. 
• Methodological quality was poor for derivation and 
good for validation studies. 
What is the implication / What should change 
now? 
• Derivation study quality should be a key factor 
when validating prescriptive CPRs. 
• Future validation studies should use controlled de- 































































Search Strategy recommendations raised concerns about
the rate of prescriptive CPR derivation study publication
without subsequent validation and stressed the need for
early replication studies and meta-analyses of rules [12] . 
A 2010 systematic review identified 14 CPRs derived
to facilitate physiotherapy-related treatment selection for
musculoskeletal conditions [6] . As only one rule [13] was
validated, [14-16] authors concluded there was limited ev-
idence to support using prescriptive CPRs in this field
[6] . Recent systematic reviews have focussed on a narrow
range of conditions, specific interventions, individual pre-
dictors, or rules that have not undergone validation [17-20] .
More focus is needed on later stages of prescriptive CPR
development to facilitate translation to practice [8 , 12 , 19] .
As validation studies should be based on methodologically
robust derivation studies, we aimed to build on Stanton
et al’s work [6] by systematically reviewing CPRs that
have undergone validation testing for predicting response
to physiotherapy-related interventions for outpatient mus-
culoskeletal conditions and to critically appraise associated
derivation studies. 
2. Methods 
2.1. Study design 
We conducted a systematic review and followed the
PRISMA guidelines for reporting this review [21] . 
2.2. Eligibility criteria 
We defined prescriptive CPRs based on the PROGno-
sis RESearch Strategy series 3 and 4 [12 , 22] . A CPR is a
statistical “combination of multiple predictors from which
risks of a specific endpoint can be calculated for individ-
ual patients”[22] . A CPR was defined as prescriptive ifthe outcome of interest was treatment response [12] . We
included studies that aimed to validate a published CPR
that stratified patients with musculoskeletal conditions to
different interventions relevant to outpatient physiotherapy
practice [6 , 23] . Only studies with a comparison or control
arm were included. We excluded impact analysis studies as
these were beyond the scope of the review aims. Detailed
eligibility criteria are presented in Appendix A. 
2.3. Search strategy 
A systematic literature search of PubMed, EMBASE,
CINAHL and Cochrane Library databases was conducted
to September 2020. We limited searches to 2007 onwards
to identify additional studies published after Stanton et al’s
review [6] . The search was not limited by language. Val-
idation studies included by Stanton et al [6] that met our
inclusion criteria were also retrieved. 
The search included three components (Appendix B): 
I. Musculoskeletal conditions commonly treated in out-
patient physiotherapy practice [6] . 
II. Interventions relevant to musculoskeletal outpatient
physiotherapy practice as per the Physiotherapy Ev-
idence Database [23] . 
III. CPRs based on a previously validated search string
[1] . 
2.4. Study selection 
Two review authors (MEW, and HPF or RG) indepen-
dently screened retrieved titles and abstracts and excluded
irrelevant studies. Full-texts of remaining articles were
independently reviewed by three review authors (MEW,
HPF, RG). Once potentially eligible validation studies were
identified, full-texts of associated derivation studies, which
aimed to derive prescriptive CPRs were obtained to con-
firm eligibility. Disagreements were resolved by consensus.
2.5. Data extraction 
We extracted the following data from validation stud-
ies: CPR features, original derivation study reference, study
design, setting, population, musculoskeletal condition, pro-
posed treatment, definition of successful outcome, follow-
up duration, sample size, and demographics. Further details
were extracted from original derivation studies. 
2.6. Risk of bias assessment 
While this review focussed on validation studies of pre-
scriptive CPRs, risk of bias in original development of
CPRs was deemed important to overall quality. We con-
ducted a two-stage process for quality appraisal, separately
assessing original derivation studies and validation stud-
ies. As there is currently no systematic framework for ap-
praising prescriptive CPRs [12] , derivation studies were





























































































assessed based on criteria guided by the PROBAST tool
for prognostic and diagnostic CPRs, as well as published
recommendations relating to prescriptive CPRs in rehabil-
itation practice [6 , 12 , 18 , 24] . Validation studies were as-
sessed using nine criteria for studies with control groups
outlined by the Cochrane Effective Practice and Organisa-
tion of Care group [25] . Additionally, deviations between
predictor and outcome definitions used by derivation and
validation studies were noted (Appendix C and D). Three
researchers (MEW, HPF and RG) independently assessed
methodological quality of each study. Each criterion was
scored as ‘high’, ‘low’ or ‘unclear’ risk of bias. Disagree-
ments were resolved by consensus. 
2.6. Summary measures 
The performance of CPRs for prognosis or diagnosis
is traditionally reported with measures of calibration and
discrimination [26] . Discrimination, quantified by the Area
Under the Curve (AUC) statistic, is the CPR’s ability to
differentiate between patients who do and do not expe-
rience the outcome [4] . In deciding what CPR threshold
to use for treatment, sensitivity and specificity at specific
cut-offs are calculated, and the relative harms of false-
positives and false-negatives considered [27] . Calibration
compares differences between predicted and observed out-
comes, presented graphically or with Hosmer-Lemeshow
statistics [28] . Positive and negative likelihood ratios (LR)
are used to quantify the number of times more likely a
patient who experiences the outcome of interest is to have
positive or negative CPR prediction [29] . Accuracy can be
considered moderate with a positive LR > 5.0 or a negative
LR < 0.20 [30 , 31] . Discrimination and calibration measures,
specifically for prescriptive CPRs have undergone devel-
opment, but are not yet widely used [27] . Therefore, we
used a descriptive approach to reporting CPR performance
including authors’ recommendations regarding the CPR’s
performance. The numbers of patients in each CPR cate-
gory in the intervention and control groups were extracted
from validation studies as well as outcomes for each group.
Where linear rather than dichotomous outcome measures
were reported, percentage change from baseline was esti-
mated based on the follow-up time-period most similar to
the derivation study [32] . Measures of discrimination, cal-
ibration, sensitivity/specificity and likelihood ratios were
also extracted. 
3. Results 
3.1. Study identification 
From a total of 6,058 studies retrieved through database
searching, eight eligible validation studies were identified
( Figure 1 ) . One additional validation study, published in
2004 was identified from Stanton et al’s. [6] systematic
review. In total, nine articles describing validation studiesof seven unique rules were included. The full-text articles
describing the seven derivation studies were retrieved. 
3.2. Characteristics of derivation and validation studies 
Characteristics of the seven derivation studies are pre-
sented in Table 1 . Six rules were developed in the USA
[13 , 33-37] and one in Spain [38] . Three CPRs were de-
rived for LBP [13 , 34 , 37] , two for neck pain [33 , 35] , one
for carpal tunnel syndrome [38] , and one for shoulder pain
[36] . Treatment options for response prediction included
manipulation/mobilisation [13 , 38] , traction [35] , exercises
[34 , 37] or a combination of treatments [33 , 36] . The num-
ber of predictors in the final CPRs varied from three [38] to
six [33] . Duration of follow-up ranged from immediate
[38] to 8 weeks [34 , 37] . 
Characteristics of the nine validation studies [14 , 16 ,
39-45] are presented in Table 2 . Five studies were based
in the USA [14 , 39 , 41 , 43 , 44] one each in Australia [16] ,
Israel [40] , Spain [42] and Brazil [45] . The CPR devel-
oped by Flynn et al [13] to predict response to spinal
manipulative therapy for LBP underwent validation testing
by three studies [14 , 16 , 43] , although Dougherty et al
[43] adapted the rule for patients with chronic rather
than acute symptoms. Each of the remaining six CPRs
underwent validation testing in one study. Table 2 outlines
which studies were also included in the review by Stanton
et al [6] . Six validation studies had longer follow-up
times than the original derivation studies [14 , 16 , 41-44]
and six used different primary outcome definitions than
the original studies [16 , 39 , 41 , 43-45] . 
3.3. Risk of bias within validation and derivation studies 
Figure 2 summarises the methodological quality of each
validation study and associated derivation study (see Ap-
pendices 2 and 3). Consensus discussion between review-
ers was required for 18% of validation studies and 21% of
derivation studies. All validation studies were randomised
controlled trials (RCTs). All used interaction tests to eval-
uate whether CPR status determined treatment success.
Overall, validation studies were of good quality. While all
studies discussed blinding, it was not clear in any stud-
ies if treating therapists, patients and outcome assessors
were all blinded to CPR status. Several validation stud-
ies reported different outcome definitions than derivation
studies and the rationale for this was not fully explained
[16 , 39 , 41 , 43-45] . 
A controlled study design was not used in any deriva-
tion study despite their aim to develop prescriptive rules.
Study designs used included prospective cohort studies (six
rules) [13 , 33-35 , 37 , 38] and a “single-arm trial” (one rule)
[36] . In derivation studies, predictors were well defined,
available at the right time and collectors were blinded or
a prospective design used in all cases. Outcome measures



























Treatment Design No. of 
predictors in 
analysis 
Definition of successful 
outcome and success 
rate 

















Improvement of > 50% 
of baseline modified 
Oswestry disability 
questionnaire 
Success rate = 32/71 
(45%) 
Five variables: 
- duration of symptoms 
< 16 days 
- at least one hip with > 
35 ° internal rotation 
- lumbar hypomobility 
- no symptoms distal to 
the knee 
- FABQ work score < 19 
≥4 variables present 
Positive rate = 45% 
(21/71) 
2–8 days AUC: N/R 
Sn: 63% (45-77%) 
Sp: 97% (87-100%) 
LR + :24.4 (4.6-139.4) 















Improvement of ≥50% 
on baseline Oswestry 
disability 
questionnaire 
Success rate = 
18/54 (33%) 
Four variables: 
- age < 40 years 
- average SLR > 91 °
- aberrant movements 
present 
- positive prone 
instability test 
≥3 variables present 
Positive rate = N/R 
8 wks AUC: N/R 
Sn: 56% (34-75%) 
Sp: 86% (71-94%) 














+ 5 or greater on Global 
Rating of Change 
scale 
Success rate = 42/78 
(54%) 
Six variables: 
- symptoms < 30 days 
- no symptoms distal to 
the shoulder 
- symptoms not 
aggravated by looking 
up 
- FABQPA score < 12 
- diminished upper 
thoracic spine kyphosis 
- cervical extension ROM 
< 30 °
≥3 variables present 
Positive rate = 47% 
(37/78) 
2–8 days AUC: N/R 
Sn: 76% (67-82%) 
Sp: 86% (75-93%) 
LR + :5.5(2.7-12.0) 
R 2 : 0.68 
Raney 2009, 
USA 










+ 6 or greater on Global 
Rating of Change 
scale 





lower spine (C4-C7) 
mobility testing 
- positive shoulder 
abduction test 
- age > 55 years 
- positive ULTT A 
- positive neck 
distraction test 
≥3 variables present 
Positive rate = 35% 
(24/68) 
3 wks AUC: N/R 
Sn: 63% (46-78%) 
Sp: 87% (73-94%) 
LR + : 4.8 (2.2-11.4) 
LR-: 0.4 (0.3-0.7) 



























Treatment Design No. of 
predictors in 
analysis 
Definition of successful 
outcome and success 
rate 

























+ 5 or greater on Global 
Rating of Change 
scale 
Success rate = 35/72 
(49%) 
Three variables: 
- Pressure pain threshold 
C5-C6 joint on affected 
side < 39.6KPa 
- Heat pain threshold 
carpal tunnel affected 
side < 39.6 degrees 
- General health of SF-36 
> 66 
≥2 variables present 
Positive rate = N/R 
Immediate AUC: N/R 
Sn: 80% (63-91%) 
Sp: 95% (81-99%) 
LR + :4.8 (3.8-57.6) 
Calibration: 
Hosmer-Lemeshow 
















+ 4 or greater on Global 
Rating of Change 
scale 
Success rate = 
49/80 (61%) 
Five variables: 
- Pain-free shoulder 
flexion of < 127 degrees 
- Shoulder internal 
rotation of < 53 degrees 
- A negative Neer test 
- Not taking medications 
of any kind for shoulder 
pain 
- Duration of symptoms 
< 90 days 
≥3 variables present 
Positive rate = 54% 
(43/80) 
2-4 days AUC: N/R 
Sn: 51% (37-65%) 
Sp: 90% (73-97%) 
LR + :5.3 (1.7-16.0) 
Calibration: 
Hosmer-Lemeshow 
(P = 0.9) 














Improvement of ≥50% 
on baseline Oswestry 
disability 
questionnaire 
Success rate = 
51/95 (54%) 
Five variables: 
- No leg symptoms in the 
last week 
- Body mass index ≥25 
kg/m 2 
- total trunk flexion ≤70 °
- Left or right hip average 
rotation ≥25 
- Duration of symptoms 
≤6 months. 
≥3 variables present 
Positive rate = 42% 
(40/95) 
8 weeks AUC: N/R 
Sn: 73% (58-84%) 
Sp: 93% (81-99%) 
LR + : 10.6 (3.5-32.1) 
LR-: 0.4 (0.3-0.7) 
Calibration: 
Hosmer-Lemeshow 
(P = 0.8) 
MSK, Musculoskeletal; AUC, Area under Curve; Sn, Sensitivity; Sp, Specificity; LR + , Positive Likelihood Ratio; LR-, Negative Likelihood Ratio; FABQ , Fear Avoidance Beliefs Questionnaire; 
FABQ PA , Fear Avoidance Beliefs Questionnaire Physical Activity subscale; N/R, Not Reported; SLR , straight leg raise; ROM , range of movement; RCT , randomised controlled trial; ULTT , 































Population Deviations from 
derivation 
study 




total, N CPR + 
(outcome)N 
CPR - (outcome) 
Control group N 









Childs 2004 a 
USA 





131 33.9 ± 10.9 42% Follow-up at 1 
wk, 4 wks and 




group, CPR status 
and time (for 
disability). 
Significant 
interaction ( P < 0.01). 
N = 70 (44% 
success at 1 
wk) 
CPR + : 23 
(68% 1-wk 
change ODI) b 
CPR -: 47 
(28% 1-wk 
change ODI) ∗
N = 61 (12% 
success at 1 
wk) 
CPR + : 24 
(17% 1-wk 
change ODI) 








Flynn 2002 a 
(Low back 
pain) 










1,2,4 and 12 




group, CPR status 
and time (for pain 
and disability). No 
significant 
interaction. 
N = 119 








N = 120 

















181 56.0 (SD 
N/R) 
33% CPR modified for 
chronic 
population (4 
of 5 predictors 
included). 
Follow-up at 
5, 12 and 






group, CPR status 
and time (for pain 
and disability). No 
significant 
interaction. 
N = 92 
CPR + : 60 
(21% change 
5-wk ODI) 
CPR -: 32 
(17% change 
5-wk ODI) 
N = 89 
CPR + : 61 
(25% change 
5-wk ODI) 




































Population Deviations from 
derivation 
study 




total, N CPR + 
(outcome)N 
CPR - (outcome) 
Control group N 


















105 36.8 (SD 
N/R) 
53% None Two-way interaction 
between treatment 




N = 48 
CPR + : 18 
(72% change 
MODI) 
CPR -: 30 
(49% change 
MODI) 
N = 57 
CPR + : 22 
(49% change 
MODI) 


















140 39.9 ± 11.3 69% GROC scale not 




group, CPR status 
and time for NDI. No 
significant 
interaction. 
N = 70 
CPR + : 33 
(55% 1-wk 
change NDI) 
CPR -: 27 (45% 
1-wk change 
NDI) 
N = 70 
CPR + : 29 
(34% 1-wk 
change NDI)) 










RCT 1 Exercise + 
Mechani- 
cal traction 





86 46.9 ± 10.7 54% Time-period 
different: 6 
months vs. 3 
wks. 
GROC scale not 




groups, CPR status 
and time for 
disability, arm pain 
and neck pain. 
Significant for 
secondary but not 
primary outcome at 6 
months. 
Intervention 1 
N = 31 
CPR + : 17 
(76% 4-wk 
change NDI) b 




N = 27 
CPR + : 13 
(74% 4-wk 
change NDI) 
CPR -: 14 (68% 
4-wk change 
NDI) 
N = 28 
CPR + : 11 
(74% 4-wk 
change NDI) 













































Population Deviations from 
derivation 
study 




total, N CPR + 
(outcome)N 
CPR - (outcome) 
Control group N 


























120 47 ± 9 100% Follow-up 
timeframe: 1, 





group, CPR status 
and time. No 
significant 
interaction. 
N = 58 
CPR + : 19 
(37% success at 
6-months) 
CPR -: 39 
(39% success at 
6-months) 
N = 60 
CPR + : 18 
(50% success at 
6-months) 
CPR -: 42 














140 42.7 ± 12.4 54% GROC scale not 




wk, 4 wks and 




group, CPR status 
and time. No 
significant 
interaction. 
N = 70 
CPR + : 29 
(17% 1-wk 
SPADI change) 




N = 70 
CPR + : 30 
(14% 1-wk 
SPADI change) 















222 47.9 ± 15.5 
(intervention) 







6-wks vs 8 wks 
Two-way interaction 
between treatment 




N = 148 








N = 74 




CPR -: 31 




RCT , randomised controlled trial; SD, Standard Deviation; CPR, Clinical Prediction Rule; GROC, Global Rating of Change; NDI, Neck Disability Index; N/R, Not Reported; 
ODI, Oswestry Disability Index; RMDQ, Roland Morris Disability Questionnaire; MODI, Modified Oswestry Disability Index; SPADI, Shoulder Pain and Disability Index 
a Included in the Stanton et al [6] review 
b % change on outcome measure estimated from graphical figures using WebPlotDigitizer [32] as not reported in tables. 
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was not explicitly described. All derivation studies had
small sample sizes ( n = 54-95). The ratio of number of pa-
tients with positive outcomes to the number of variables in
multivariable analysis ranged from 2 to 5, when PROBAST
recommends inclusion of at least 20 for valid analysis [5] .
All derivation studies dichotomised continuous predictor
variables using data-driven methods. Information relating
to handling of missing data or internal validation tech-
niques was not reported. 
3.4. Performance of CPRs within derivation and 
validation studies 
No derivation studies reported model discrimination us-
ing the AUC values, although all studies reported sensi-tivity/specificity with corresponding likelihood ratios. Es-
timates of specificity were higher than sensitivity for all
rules, indicating that the rules were designed for identify-
ing patients who were most likely to respond to treatment,
rather that ruling out those who would not respond. Only
three studies reported Hosmer-Lemeshow tests of calibra-
tion [36-38] . Three studies reported the R 2 measure of ex-
plained variation [13 , 33 , 36] . 
Only one validation study [14] reported a positive inter-
action test and recommended use of the CPR derived by
Flynn et al [13] . Two subsequent validation studies of this
rule in broader populations did not replicate these find-
ings [16 , 43] . The validation study for the CPR predict-
ing response to traction for neck pain found a significant
interaction for the secondary outcome but, due to small
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treatment effects, did not recommend the CPR for clini-
cal use [41] . The validation study for the rule to predict
response to stabilisation exercises for LBP found a big-
ger change in disability scores in the target group (who
received the intervention and were positive for the CPR)
than in any other group ( Table 2 ), [40] but the interac-
tion test was not statistically significant, potentially due to
study power. All other validation studies found no statisti-
cally significant interaction test and concluded that CPRs
had not been validated [39 , 42 , 44 , 45] . 
4. Discussion 
4.1. Summary of findings 
To our knowledge, this is the first systematic review
to appraise CPRs that have undergone validation testing
for predicting response to physiotherapy-related interven-
tions across a range of musculoskeletal conditions. We
identified seven eligible CPRs for use in low back pain,
neck pain, shoulder pain and carpal tunnel syndrome to di-
rect treatment options including manipulation/mobilisation
techniques, traction, exercises, or combined treatments.
Nine studies conducted validation of these seven CPRs,
representing an additional seven validation studies of pre-
scriptive CPRs using controlled designs since publication
of Stanton et al’s systematic review in 2010. Seven valida-
tion studies failed to demonstrate a statistically significant
association between CPR status and treatment outcome. 
4.2. Results in the context of the current literature 
Categorising patients who respond optimally to particu-
lar treatments may potentially improve patient and process
outcomes including waiting lists and inappropriate referrals[46 , 47] . Musculoskeletal conditions, for example chronic
LBP, have high personal and societal burden but trials of
interventions for these conditions have achieved only small
to modest benefits, potentially due to diversity in patient
profile and presentation [47-49] . This increased focus on
identifying characteristics of patients who respond best to
specific treatments has resulted in the derivation of several
prescriptive CPRs relevant to this field [6 , 46 , 47] . Our re-
view sought to synthesise CPRs that have undergone vali-
dation testing. However, the lack of control groups in origi-
nal derivation studies limits their ability to differentiate be-
tween factors that modify treatment effect and non-specific
prognostic predictors, thereby restricting the utility of the
CPR to determine treatment outcome [28 , 46] . 
The usefulness of derivation studies identified in this re-
view is also limited by statistical techniques used. Specif-
ically, all studies included a large number of candidate
predictor variables considering their relatively low sample
sizes. Childs and Cleland [30] argued that smaller sample
sizes may be acceptable in this field given the relatively
low clinical consequences of failing to identify patients
likely to benefit from specific musculoskeletal treatment
and the high pretest probability of achieving a successful
outcome which would result in higher event to predictor
ratios. The inclusion of a large number of variables how-
ever, can result in overfitting of the rule to the derivation
dataset and decreased likelihood that the CPR will be vali-
dated in future studies [28] . This problem can be overcome
by carefully choosing the most clinically relevant candidate
predictors [28] . Using data-driven methods to define cut-
points for specific predictors, as conducted in several of
the included derivation studies, can also lead to overfitting
[4] . Derivation studies should report full regression coeffi-
cients and intercepts of final models so that CPRs can be
refined and improved in subsequent studies [4 , 28] . 



























































































Our findings are in keeping with previous systematic
reviews of prescriptive CPRs. Two validation studies that
tested the CPR developed by Flynn et al [13 , 14 , 46] have
been appraised in three previous reviews [6 , 17 , 19] , while
two validation studies for neck pain CPRs [39 , 42] were
appraised in 2017 [50] . We identified four further valida-
tion studies published since 2014 that demonstrate similar
limitations to those previously identified, namely lack of
blinding of treating therapists and outcome assessors. 
Seven validation studies deviated from the derivation
study in use of outcome measures and reasons for these
deviations have not been reported. This limits the con-
clusions that can be drawn about repeatability of the de-
rived rules. Six derivation studies have been previously
appraised across three systematic reviews with broader in-
clusion criteria [6 , 18 , 20] . Our review highlights that these
methodological concerns prevail, even though only rules
that progressed to validation testing were included. 
This review focused on prescriptive CPRs meeting the
PROGRESS definition [12 , 22] . Other screening tools that
aim to stratify patients with musculoskeletal conditions
into specific treatment pathways have been developed, for
example the STarT Back Screening Too l [53,54] but these
are outside the scope of this review. Potentially, CPRs in
this field may have greater clinical benefit when used as
part of a broader strategy of stratified medicine. For ex-
ample, several validated diagnostic and prescriptive CPRs
could be combined to stratify patients with back or neck
pain into specific subgroups for treatment. This warrants
further research. 
4.3. Limitations 
This review examined the totality of evidence regard-
ing CPRs that have undergone validation testing for pre-
dicting response to physiotherapy interventions for mus-
culoskeletal conditions. Robust, systematic and transparent
methods were used to identify and select relevant stud-
ies. However, findings should be interpreted in the context
of relatively limited published guidance for prescriptive
CPRs in comparison to prognostic and diagnostic rules.
We defined prescriptive CPRs based on the PROGnosis
RESearch Strategy series 3 and 4 [12 , 22] and completed
a two-step quality appraisal process based on recent pub-
lished criteria for prognostic, prescriptive and controlled
studies [5 , 6 , 12 , 18 , 24 , 25] . There is, however, no suitable
validated tool to quality appraise controlled-design vali-
dation studies of prescriptive rules [12] . Notwithstanding
these caveats, several substantial methodological shortcom-
ings were common across all CPRs, including the lack of
a control group in derivation studies [6] , inadequate sam-
ple sizes, over-emphasis on univariable associations and
dichotomisation of variables early in the development pro-
cess [5 , 18 , 46] . Furthermore, additional research into opti-
mal performance measures for prescriptive CPRs and guid-ance on how to interpret these measures is urgently re-
quired [26 , 27] . 
4.4. Clinical implications 
Evidence from the broader CPR literature indicates that
there is an increasing number of CPRs at the derivation
stage with only a small number progressing to valida-
tion stage and very few CPRs undergoing impact analy-
sis [6] . Impact analysis studies are essential to determine
whether incorporating CPRs into a decision-making pro-
cess improves patient outcomes [51,52] . While many phys-
iotherapists in musculoskeletal practice are aware of CPRs
they may not use them routinely [9] . Qualitative research
has suggested that CPRs are most acceptable to clinicians
when they can be easily memorised, do not involve spe-
cific equipment, are applied to well-defined patient presen-
tations and are accurate enough to consistently outperform
clinical reasoning [10] . Strategies that facilitate clinician
motivation, allow administrative flexibility and assist clin-
icians in communicating the results of the CPRs easily
could promote their adoption [52 , 55] . 
Our findings do not support the use of any of the
CPRs identified to aid physiotherapy treatment selection
for adults presenting with LBP, neck pain, shoulder pain
or carpal tunnel syndrome. Further appropriately designed
validation studies are required, which should focus on at-
tempting to validate CPRs that have been derived using
controlled study designs of sufficient sample size, where
full regression models are reported to allow for calibra-
tion and refinement [4] . Up to 2010 no derivation studies
had been conducted using controlled designs [6] . This re-
view did not aim to identify derivation studies and it is
possible that further high-quality derivation studies are re-
quired. Validation studies should consider optimal blinding
to CPR status of treating therapists, patients and outcome
assessors. Furthermore, they should report outcomes us-
ing the same definitions as derivation studies to facilitate
assessment of calibration of CPRs. 
5. Conclusion 
This review identified seven prescriptive CPRs that have
undergone validation testing for use in musculoskeletal
physiotherapy practice. Findings do not support the use of
any of the CPRs identified to aid treatment selection for
adults presenting with low back pain, neck pain, shoulder
pain or carpal tunnel syndrome due to the methodological
shortcomings in the derivation of these CPRs and lack of
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